Not recruiting
Thalassaemia beta
Not recruitingLong-Term Safety and Efficacy Study of Betibeglogene Autotemcel Gene Therapy for Patients with Transfusion-Dependent Beta-Thalassemia
InvestigationalNo placebo
Long-Term Safety and Efficacy Study of Betibeglogene Autotemcel Gene Therapy for Patients with Transfusion-Dependent Beta-Thalassemia
InvestigationalNo placebo
- Disease:Thalassaemia beta
- Substances:Betibeglogene Autotemcel
Countries:
France
France- Participants:0–17 years · 18–64 years
- Substances:Betibeglogene Autotemcel



